← All Seelos Therapeutics, INC filings

Seelos Therapeutics, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
SEELQ
Seelos Therapeutics, INC
10-Q: Seelos Therapeutics Reports Mixed Q2 Results Amid Strategic Shift Towards Mental Health
Seelos Therapeutics announces Q2 2024 financial results, highlighting a strategic focus on mental health initiatives and ongoing efforts to address financial challenges.
OTC.Pink
SEELQ
Seelos Therapeutics, INC
10-Q: Seelos Therapeutics Reports Financial Results and Provides Business Update for the First Quarter of 2024
Seelos Therapeutics, a clinical-stage biopharmaceutical company, announced its financial results for the first quarter of 2024 and provided updates on its clinical programs, highlighting challenges and strategic decisions.